Cargando…
Bioavailability of Epigallocatechin Gallate Administered with Different Nutritional Strategies in Healthy Volunteers
The flavanol epigallocatechin gallate (EGCG) is being tested for the treatment of several diseases in humans. However, its bioavailability and pharmacokinetic profile needs a better understanding to enable its use in clinical trials. There is no consensus on the most appropriate concentration of EGC...
Autores principales: | Andreu Fernández, Vicente, Almeida Toledano, Laura, Pizarro Lozano, Nieves, Navarro Tapia, Elisabet, Gómez Roig, María Dolores, De la Torre Fornell, Rafael, García Algar, Óscar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278615/ https://www.ncbi.nlm.nih.gov/pubmed/32438698 http://dx.doi.org/10.3390/antiox9050440 |
Ejemplares similares
-
Effect of Postnatal Epigallocatechin-Gallate Treatment on Cardiac Function in Mice Prenatally Exposed to Alcohol
por: Andreu-Fernández, Vicente, et al.
Publicado: (2023) -
Epigallocatechin Gallate Ameliorates the Effects of Prenatal Alcohol Exposure in a Fetal Alcohol Spectrum Disorder-Like Mouse Model
por: Almeida-Toledano, Laura, et al.
Publicado: (2021) -
Bioaccessibility and Bioavailability of (-)-Epigallocatechin Gallate in the Bread Matrix with Glycemic Reduction
por: Li, Lanqi, et al.
Publicado: (2022) -
Formulation and Optimization of Nanospanlastics for Improving the Bioavailability of Green Tea Epigallocatechin Gallate
por: Mazyed, Eman A., et al.
Publicado: (2021) -
Food Inhibits the Oral Bioavailability of the Major Green Tea Antioxidant Epigallocatechin Gallate in Humans
por: Naumovski, Nenad, et al.
Publicado: (2015)